Le Dr Orasa Teerakul est spécialisée en obstétrique et gynécologie, formée dans la meilleure institution médicale de Thaïlande, l'hôpital Siriraj.
Le Dr Combo est spécialisé en oncologie gynécologique avec une formation avancée au MD Anderson Cancer Center. Il se concentre sur les techniques mini-invasives pour les cancers de l'utérus.
Le professeur Dan Grisaro est un spécialiste de premier plan en oncologie gynécologique, avec des recherches approfondies sur le cancer du col de l'utérus et les thérapies ciblées.
Spécialisé dans les chirurgies gynécologiques mini-invasives, y compris les procédures de fertilité avancées à l'hôpital Intrarat.
Le Dr Dissatat Budhithada est spécialisé dans les soins gynécologiques à l'hôpital Intrarat, avec un accent sur la santé reproductive des femmes.
_doctor_7325_années_ de spécialisation en oncologie gynécologique – Le Dr Guven réalise des chirurgies cancéreuses complexes, y compris la trachélectomie, avec des techniques mini-invasives.
Médecin-chef d'un centre de cancérologie interdisciplinaire certifié – Le Dr Viola Fox est spécialisée dans les traitements complets des tumeurs, y compris l'immunothérapie et le diagnostic moléculaire.
Dediye Dagdeviren apporte une perspective unique à la trachélectomie, combinant une formation chirurgicale approfondie et une spécialisation dans la préservation de la fertilité.
Chef du service d'obstétrique et de gynécologie à Quirónsalud Marbella, le Dr Blanco Herraez dirige une équipe multidisciplinaire axée sur la santé des femmes et les soins personnalisés.
Le Dr Séverine Iborra est spécialisée en oncologie gynécologique et en procédures mini-invasives, y compris la trachélectomie. En tant que médecin-chef au Städtisches Klinikum Solingen, elle dirige un service de gynécologie complet.
Le Prof. Eken dirige l'unité de FIV à l'hôpital Bahçeşehir University Medical Park Göztepe, se spécialisant dans les chirurgies gynécologiques complexes.
Le Dr Alemdar est spécialisé dans la trachélectomie (cervicectomie) au complexe hospitalier Medical Park Antalya, apportant une formation approfondie en oncologie médicale.
Le Dr Kevser Arkan, MD, est sous-spécialiste en chirurgie oncologique gynécologique (gynécologie-obstétrique) au sein du groupe OPTIMED Health Group à Çorlu et Çerkezköy. Elle y travaille depuis 2026. Elle dispense des soins en anglais et en turc.
Son domaine clinique est la prise en charge chirurgicale des cancers de l'ovaire, de l'endomètre et du col de l'utérus. Elle réalise des interventions pelviennes complexes, notamment l'hystérectomie radicale, la lymphadénectomie avec cartographie des ganglions sentinelles et la chirurgie de cytoréduction. Elle propose une chirurgie mini-invasive, incluant le vNOTES (laparoscopie sans cicatrice), la laparoscopie, la laparotomie et l'hystéroscopie. Elle pratique également la reconstruction urogynécologique, y compris la sacrocolpopexie. Elle gère les grossesses à haut risque.
Diplômes : MD, Université de Gaziantep (2016). Résidence en gynécologie-obstétrique, Université Kahramanmaraş Sütçü İmam (2016–2021). Fellowship en chirurgie oncologique gynécologique, Hôpital de formation et de recherche Gazi Yaşargil de Diyarbakır (2022–2025). Expérience : Hôpital mère-enfant de Diyarbakır, Clinique d'oncologie gynécologique (2022–2025). Hôpital d'État d'Adıyaman Kahta (2021–2022). Giresun Alucra TSM (2016).
Travaux académiques : En 2025, elle a publié des études évaluées par des pairs sur la cartographie des ganglions sentinelles dans la stadification du cancer de l'endomètre par vNOTES et sur les résultats comparatifs entre vNOTES et laparoscopie. Elle a également publié des travaux sur le prolapsus des organes pelviens et la fonction sexuelle, les régimes de folate pour les tumeurs trophoblastiques gestationnelles (GTN) et la sacrocolpopexie assistée par vNOTES. Ses articles sont parus dans des revues telles que BMC Surgery, Scientific Reports, Journal of Clinical Medicine et Ginekologia Polska.
Le Dr Roy Mashiach est directeur du service de gynécologie au centre médical Sheba en Israël. Il est spécialisé dans la chirurgie gynécologique mini-invasive et les procédures de préservation de la fertilité. Le Dr Mashiach a reçu le prix Daniel F. Kott pour l'innovation chirurgicale de l'AAGL.
Premier gynécologue au monde accrédité par la SERGS pour opérer avec deux plateformes robotiques – le Dr Stanciu est spécialisé dans les chirurgies préservant la fertilité pour les jeunes patientes atteintes de cancer au Ponderas Academic Hospital.
Zhang Jinshan, male, China’s First M.D. in the Radiation Medicine, CCI (Chinese College of Interventionalists) Master Interventionalist, Director of the Department of Former Radiological Diagnosis at Chinese PLA General Hospital(No.3 in China) Ph.D. of Medicine, Nagasaki University, Japan.
1980–1985: Completed doctoral studies at Nagasaki University, Japan
1968–present: Department of Radiology, Chinese PLA General Hospital
1988: Third Prize of the Military Science and Technology Progress Award
1989–present: Member of Radiological Society of North America(RSNA)
1990–2009: Standing Committee Member of the Radiology and Therapeutic Radiology Committee of the PLA
1991: Second Prize of the Military Science and Technology Progress Award
1992–2008: Group Leader of the Group of Intervention of Chinese Journal of Radiology
1992–2015: Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology
1993: Granted the Lifetime Special Government Allowance of the State Council
1993–2012: Deputy Chief Editor of Chinese Journal of Medical Image Technology
1994: Third Prize of the Military Science and Technology Progress Award
1997: Second Prize of the Military Science and Technology Progress Award
1997–2009: Standing Member of Chinese Society of Radiology
1999: Third Prize of the Military Science and Technology Progress Award
1999–2010: Deputy Director Member of Chinese Society of Interventional Oncology
2002: Second Prize of the Military Science and Technology Progress Award
2005: Third Prize of the Military Science and Technology Progress Award
Member of Radiological Society of North America(RSNA)
Standing Member of Chinese Society of Radiology
Group Leader of the Group of Intervention of Chinese Journal of Radiology
Deputy Director Member of Chinese Society of Interventional Oncology
Director Member of Beijing Medical Association Society of Interventional Radiology
Deputy Chief Editor of Chinese Journal of Medical Image Technology
Standing Member of Professional Committee of Radiological Medicine of the Chinese People’s Liberation Army
Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology
Awarded the Special Government Allowance of the State Council
Awarded three Second Prizes and four Third Prizes for Military Science and Technology Progress.
Awarded the honorary title of “Chinese College of Interventionalists(CCI) Master Interventionalist”
Led multiple national and provincial/ministerial scientific research projects, including two projects funded by the National Natural Science Foundation of China and two projects funded by the Department of Science and Technology of Sichuan Province.
In the pioneering development of interventional medicine in China, Zhang Jinshan has been an indispensable founder and leading figure. As China’s first overseas-trained doctoral graduate in radiological medicine, he returned to China in the 1980s after completing his studies abroad and introduced cutting-edge international interventional technologies to the country. Over more than four decades of dedicated practice and research, he has helped propel Chinese interventional medicine from its infancy to a position at the forefront of the global field through his exceptional clinical expertise and profound academic accomplishments.
Professor Zhang Jinshan has long been dedicated to the field of medical imaging and has developed distinctive expertise in selective and superselective interventional diagnosis and treatment for solid tumors such as liver cancer, demonstrating exceptional technical proficiency and profound academic accomplishment. Beginning in the 1990s, he led his team in pioneering the clinical application and research of TIPSS and B-ORTO in China, filling major gaps in the domestic field and opening new paths for the interventional management of gastrointestinal bleeding caused by portal hypertension secondary to liver cirrhosis. In addition, he has made groundbreaking contributions to the interventional diagnosis and treatment of peripheral vascular diseases, as well as to preoperative embolization for spinal tumors.
In the field of liver cancer treatment, Professor Zhang Jinshan not only led the development of standardized treatment protocols for liver cancer but also pioneered Transcatheter Arterial Chemoembolization with temporary Hepatic Vein Thrombosis (TACE-THVO) for primary liver cancer, bringing the efficacy of interventional therapy to a new level. In recognition of his outstanding clinical and scientific contributions, he was awarded the honorary title of “Chinese Master of Interventional Radiology” at the 2019 annual conference of the Chinese College of Interventionalists.
Professor Zhang Jinshan is not only a master clinician but also a driving force in the development of the discipline and a dedicated mentor in talent cultivation. He led his team in establishing one of China’s premier interventional therapy centers. As a doctoral supervisor, he has trained a large number of outstanding specialists and future leaders in interventional medicine, with many of his students and protégés now serving across the country. Academically, he has led multiple key national and military research projects, published more than 300 academic papers, and served as chief editor of three monographs, making remarkable contributions to the establishment of China’s academic framework for interventional medicine and the nationwide dissemination of its technologies.
From the laboratory to the operating room, and from academic podiums to grassroots hospitals, Professor Zhang Jinshan has consistently upheld the principles of “pioneering, innovation, pragmatism, and compassion". He has devoted his life to fulfilling the mission of a physician—relieving patients’ suffering through minimally invasive techniques and advancing the discipline through academic excellence—thereby establishing himself as a truly towering figure and one of the foremost authorities in the field of interventional medicine in China.
Professor Zhang Jinshan has achieved prolific academic accomplishments, having published over 300 academic papers covering areas such as interventional therapy for liver cancer, minimally invasive treatment of portal hypertension, interventional treatment of vascular diseases, and tumor ablation.
1. Zhang Jinshan, Wang Maoqiang. Experiments and Clinical Studies of transjugular intrahepatic portosystemic stent shunt (TIPSS). Chinese Journal of Radiology, 1993，27（6）：361-365.
Professor Zhang Jinshan is the first author. This is one of the early research papers in China that systematically elaborates on the TIPSS technique. Through animal experiments and clinical case analysis, it confirmed that TIPSS is a safe and effective minimally invasive method for treating portal hypertension and its complications, laying an important foundation for the promotion and application of this technique in China.
2.Zhang Jinshan, Li Huai. Clinical study on transcatheter arterial embolization with temporary hepatic vein occlusion for the treatment of primary liver cancer.Chinese Journal of Radiology, 1996，30（8）：521-524.
Professor Zhang Jinshan is the first author. He innovatively proposed the technique of "transcatheter arterial embolization with temporary hepatic vein occlusion." Clinical results demonstrated that this method can significantly increase the drug concentration within liver cancer lesions, reduce damage to normal liver tissue, and effectively improve the therapeutic outcomes for intermediate and advanced liver cancer, providing a novel strategy for the interventional treatment of liver cancer.
3. Zhang Jinshan, Wang Maoqiang, Li Huai. Interventional treatment of Budd-Chiari syndrome. Chinese Journal of Medical Imaging Technology, 1998，14（3）：189-191.
Professor Zhang Jinshan is the first author. This paper systematically summarizes the early experience in interventional treatment of Budd-Chiari syndrome in China, elaborating in detail on the key operational points and therapeutic efficacy of techniques such as percutaneous transluminal angioplasty and stent placement. It confirms that interventional therapy is the preferred minimally invasive method for Budd-Chiari syndrome, promoting the standardized development of treatment for this disease.
4.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical value of superselective hepatic arterial chemoembolization in the treatment of hypovascular liver cancer. Chinese Journal of Radiology, 2000，34（5）：335-337.
Professor Zhang Jinshan is the first author. Addressing the challenges in interventional treatment of hypovascular liver cancer, this paper explores the clinical efficacy of superselective hepatic arterial chemoembolization. The results indicate that this technique can precisely target the lesions and improve the treatment response rate, providing an important clinical basis for the interventional treatment of hypovascular liver cancer.
5. Zhang Jinshan, Li Huai, Wang Maoqiang. Interventional treatment of peripheral vascular stenosis and occlusion.Chinese Journal of Radiology, 2002，36（7）：612-614.
Professor Zhang Jinshan is the first author. This paper summarizes the interventional treatment experience of over 400 patients with peripheral vascular stenosis and occlusion, analyzing the indications and efficacy of techniques such as balloon angioplasty and stent placement. It confirms that interventional therapy is a safe and effective approach for peripheral vascular diseases, providing practical support for its clinical promotion.
6.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical application of CT-guided percutaneous puncture ablation in the treatment of abdominal tumors. Chinese Journal of Medical Imaging Technology, 2004，20（9）：1395-1397.
Professor Zhang Jinshan is the first author. This paper explores the application value of CT-guided percutaneous puncture techniques such as radiofrequency ablation and chemical ablation in the treatment of abdominal tumors. The clinical results show that this method is minimally invasive with reliable efficacy, offering a minimally invasive treatment option for patients with inoperable abdominal tumors.
7.Zhang Jinshan, Wang Maoqiang, Li Huai. Advances in the application of interventional therapy for benign prostatic hyperplasia. Chinese Journal of Radiology, 2006，40（8）：876-878.
Professor Zhang Jinshan is the corresponding author. This paper systematically reviews the cutting-edge advances in interventional therapy for benign prostatic hyperplasia, including the principles, procedures, and efficacy of techniques such as prostatic artery embolization and stent placement, providing new insights for the minimally invasive treatment of benign prostatic hyperplasia.
8.Zhang Jinshan, Li Huai, Wang Maoqiang. Discussion on the standardization of interventional therapy for liver cancer. Chinese Journal of Practical Surgery, 2008，28（10）：856-858.
Professor Zhang Jinshan is the corresponding author. Drawing on years of clinical experience and research findings, he led the discussion on standardized protocols for interventional therapy of liver cancer, covering key aspects such as preoperative assessment, treatment modality selection, and postoperative management, providing important references for the formulation of clinical guidelines for interventional therapy of liver cancer in China.
1. Interventional Radiology (People's Military Medical Press, 1995): The first monograph in China to systematically discuss the theories and techniques of interventional radiology. It comprehensively elaborates on the interventional diagnosis and treatment system for tumors, vascular diseases, and non-vascular diseases, becoming a classic essential textbook for interventional physicians in China.
2.Interventional Therapy for Liver Cancer (People's Health Press, 2001): Focusing on minimally invasive interventions for liver cancer, this book systematically summarizes techniques such as TACE, ablation, and vascular intervention, refines operational standards and the prevention and management of complications, and promotes the standardization of interventional therapy for liver cancer.
3.Interventional Treatment of Portal Hypertension (Science Press, 2005): This book systematically elaborates on minimally invasive techniques for portal hypertension, such as TIPSS and B-ORTO, covering experimental research, clinical procedures, long-term follow-up, and efficacy evaluation, filling the gap in monographs on interventional treatment of portal hypertension in China.
1.The National "Eighth Five-Year Plan" Scientific and Technological Key Project—Clinical and Basic Research on Comprehensive Interventional Therapy for Liver Cancer (Project Leader): This project systematically explored multimodal interventional strategies for liver cancer, established the core regimen of superselective TACE combined with local ablation, and significantly improved the therapeutic outcomes for intermediate and advanced liver cancer.
2.The Military "Ninth Five-Year Plan" Key Medical Scientific Research Project—Standardized Research on TIPSS for the Treatment of Portal Hypertension (Project Leader): This project formulated China's first operational standards and postoperative management guidelines for TIPSS, reduced the incidence of complications, and promoted the popularization of this technique throughout the military and across the country.
3.National Natural Science Foundation of China Project — Research on the Mechanism of Targeted Therapy for Liver Cancer Using Hepatic Vein Occlusion Combined with Chemoembolization (Project Leader): This project revealed the synergistic enhancement mechanisms of the innovative technique at the levels of hemodynamics, drug metabolism, and the tumor microenvironment, providing theoretical support for precision interventional therapy of liver cancer.
4.Military Clinical High-Tech Major Project-Establishment and Clinical Application of the Interventional Treatment Technology System for Complex Vascular Diseases (Project Leader): This project overcame interventional challenges in complex lesions such as Budd-Chiari syndrome, peripheral vascular occlusion, and vascular malformations, forming a complete technical system that has been promoted and applied widely.
Le Dr Kim Tae Joong est spécialisé en oncologie gynécologique au Samsung Medical Center.
Le Dr Lee Jeong Won est spécialisé en oncologie gynécologique, avec un accent sur les cas complexes au Samsung Medical Center.
Professeur et spécialiste en oncogynécologie, Gilad Ben Baruch apporte une expertise ciblée dans les procédures de trachélectomie au centre médical Assuta.